WC
XGN icon

Wexford Capital’s Exagen XGN Stock Holding History

Wexford Capital’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Hold
792,855
– – 0.47% 30
2026
Q1 		$2.38M Buy
792,855
+326,077
+70% +$1.26M 0.34% 35
2025
Q4 		$2.84M Buy
466,778
+21,851
+5% +$199K 0.55% 33
2025
Q3 		$4.89M Buy
444,927
+28,579
+7% +$253K 0.7% 19
2025
Q2 		$2.91M Buy
+416,348
New +$2.53M 0.81% 21

Other funds holding XGN

NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wexford Capital's XGN Position: Q2 2026 in Review

Wexford Capital held its Exagen (XGN) position steady in Q2 2026 at 792,855 shares worth $3.69M. The position accounts for 0.47% of the portfolio, ranked #30.

Wexford Capital first reported a position in XGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.89M in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Wexford Capital held 792,855 shares of Exagen worth $3.69M as of Q2 2026.
  • Wexford Capital left its Exagen share count unchanged in Q2 2026.
  • Exagen made up 0.47% of Wexford Capital's portfolio in Q2 2026, its #30 holding.
  • Wexford Capital first reported a position in Exagen in Q2 2025 and has held it in 5 quarters since.
  • Wexford Capital's Exagen position peaked at $4.89M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Wexford Capital's 13F filing for Q2 2026, filed 14 Aug 2026.